Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Mulligan v. Aceto Corporation et al
Case Number:
2:18-cv-02425
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Abell Eskew
- Ellis George
- Friedman Kaplan
- Glancy Prongay
- Levi & Korsinsky
- Pomerantz LLP
- Robbins Geller
Companies
Sectors & Industries:
-
March 17, 2021
Aceto Investors Can't Resurrect Securities Suit
Investors in pharmaceutical company Aceto Corp. can't get their securities fraud suit against the company revived on the basis of a recent Second Circuit opinion, a New York federal judge has determined.
-
August 04, 2020
Aceto Shareholders Lose Last Shot At Lawsuit
A Brooklyn federal judge has permanently tossed out a shareholders' lawsuit against former directors and officers of pharmaceutical company Aceto Corp., finding the company had fulfilled its obligations to warn investors about the risks a supply issue would pose to the company in advance of problems with a key supplier.
-
August 07, 2019
Aceto, 3 Execs Escape Stock-Drop Suit For Now
A Brooklyn federal judge dismissed a shareholder derivative suit against pharmaceutical company Aceto Corp. and three executives, finding that the struggling company did not mislead investors by failing to predict the troubles that shut it down.